Evidence map›Paper›PMID 34764137›Full record

ArticleGenes & development2021

The evolution of metazoan shelterin.

Logan R Myler, Charles G Kinzig, Nanda K Sasi, George Zakusilo, Sarah W Cai, Titia de Lange

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Establishment and Characterization of a Chicken Myoblast Cell Line.International journal of molecular sciences · 2024
    Article
  5. Article
  6. Article
  7. Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Article
  9. POT1 recruits and regulates CST-Polα/Primase at human telomeres.bioRxiv : the preprint server for biology · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Telomerase structural biology comes of age.Current opinion in structural biology · 2022
    Review
  18. Review
  19. Shelterin is a dimeric complex with extensive structural heterogeneity.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Logan R Myler *Laboratory for Cell Biology and Genetics, The Rockefeller University, New York, New York 10021, USA.
Charles G Kinzig *Laboratory for Cell Biology and Genetics, The Rockefeller University, New York, New York 10021, USA.
Nanda K SasiLaboratory for Cell Biology and Genetics, The Rockefeller University, New York, New York 10021, USA.
George ZakusiloLaboratory for Cell Biology and Genetics, The Rockefeller University, New York, New York 10021, USA.
Sarah W CaiLaboratory for Cell Biology and Genetics, The Rockefeller University, New York, New York 10021, USA.
Titia de LangeLaboratory for Cell Biology and Genetics, The Rockefeller University, New York, New York 10021, USA.ORCID 0000-0002-9267-367X
Rockefeller University · US

Funding

Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
MECHANISMS OF TELOMERE INDUCED SENESCENCER01AG016642 · NIA · ROCKEFELLER UNIVERSITY · PI Titia de Lange · 1999 to 2026
$11.9M
Genome instability in cancer: telomeres and DNA repairR35CA210036 · NCI · ROCKEFELLER UNIVERSITY · PI Titia de Lange · 2016 to 2026
$10.8M
Mechanism of the telomeric proliferation limitR56AG016642 · NIA · ROCKEFELLER UNIVERSITY · PI DE LANGE, TITIA · 2019 to 2019
$598k
Single-Molecule Studies of Human DNA Double Strand Break RepairK00CA212452 · NCI · ROCKEFELLER UNIVERSITY · PI MYLER, LOGAN ROSS · 2018 to 2021
$376k
Telomerase-Mediated Healing of Double-Strand Breaks in Human CellsF30CA257419 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI KINZIG, CHARLES GUNNAR · 2021 to 2024
$189k
NCI NIH HHS F30 CA257419NCI NIH HHS K00 CA212452NCI NIH HHS R35 CA210036NIA NIH HHS R01 AG016642NIA NIH HHS R56 AG016642NIGMS NIH HHS T32 GM007739
6 · The paper itself

Abstract

The mammalian telomeric shelterin complex-comprised of TRF1, TRF2, Rap1, TIN2, TPP1, and POT1-blocks the DNA damage response at chromosome ends and interacts with telomerase and the CST complex to regulate telomere length. The evolutionary origins of shelterin are unclear, partly because unicellular organisms have distinct telomeric proteins. Here, we describe the evolution of metazoan shelterin, showing that TRF1 emerged in vertebrates upon duplication of a TRF2-like ancestor. TRF1 and TRF2 diverged rapidly during vertebrate evolution through the acquisition of new domains and interacting factors. Vertebrate shelterin is also distinguished by the presence of an HJRL domain in the split C-terminal OB fold of POT1, whereas invertebrate POT1s carry inserts of variable nature. Importantly, the data reveal that, apart from the primate and rodent POT1 orthologs, all metazoan POT1s are predicted to have a fourth OB fold at their N termini. Therefore, we propose that POT1 arose from a four-OB-fold ancestor, most likely an RPA70-like protein. This analysis provides insights into the biology of shelterin and its evolution from ancestral telomeric DNA-binding proteins.

Indexed as

Telomeric Repeat Binding Protein 2Tripeptidyl-Peptidase 1AnimalsMammalsShelterin ComplexTelomereTelomere-Binding ProteinsShelterin ComplexTelomere-Binding ProteinsTelomeric Repeat Binding Protein 2Tripeptidyl-Peptidase 1ApolloevolutionMCPH1NBS1PNUTSPOT1Rap1shelterintelomerasetelomereTIN2TPP1TRF1TRF2

Identifiers

PMID34764137
PMCPMC8653790
OpenAlexW3212889910

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.